Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion
Visit http://www.ecancer.org for more.
Prof Giagounidis (St. John’s Hospital, Duisburg, Germany) chairs a discussion with Dr Zaja (University of Udine, Udine, Italy), Dr Liebman (University of Southern California, Los Angeles, USA), and Dr Bussel (Cornell University, Ithaca, USA) for ecancertv at EHA 2014 about the latest in ITP treatment options.
In particular, they discuss the latest clinical evidence and best treatment practice in chronic adult ITP, present the latest long-term data for TPO-R agonists with a focus on eltrombopag, and give expert insight into the management of challenging cases of chronic adult ITP.
Read the prescribing information here: http://share.ecancer.org/GSKEHAPrescribingInformation.pdf
Content taken from a GlaxoSmithKline sponsored satellite symposium at EHA 2014 as part of the official programme.
Date of preparation: July 2014, OF/ELT/0079/14a
Видео Treatment options in adult chronic idiopathic thrombocytopenic purpura: Panel discussion канала ecancer
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
![Strategies for Managing Immune Thrombocytopenia](https://i.ytimg.com/vi/WnVM1VbTrfY/default.jpg)
![ITP Treatment Selection Criteria and Treatment Goals](https://i.ytimg.com/vi/cTu1PO-hePE/default.jpg)
![Rituximab and Salvage Therapies for Patients With ITP](https://i.ytimg.com/vi/ZAobKyNpwj8/default.jpg)
![Immune Thrombocytopenia (ITP): Advances in Treatment in 2020](https://i.ytimg.com/vi/na2w5RsFQdI/default.jpg)
![Treatment of Idiopathic Thrombocytopenic Purpura (ITP)](https://i.ytimg.com/vi/nxdx_Zo0ZaU/default.jpg)
![How to make diseases disappear | Rangan Chatterjee | TEDxLiverpool](https://i.ytimg.com/vi/gaY4m00wXpw/default.jpg)
![Key Insights: Real-World Evidence for ITP Treatment](https://i.ytimg.com/vi/2AHNgKF9S-w/default.jpg)
![Publication in Practice: Immune Thrombocytopenia Purpura](https://i.ytimg.com/vi/nFF3SgUpyuo/default.jpg)
![Thrombocytopaenia (low platelets) Overview - platelet physiology, classification, pathophysiology](https://i.ytimg.com/vi/JF4ERKr_CnI/default.jpg)
![First-Line Therapy Options for Patients with ITP](https://i.ytimg.com/vi/D0my-1D0HkQ/default.jpg)
![Rational Approach to Evaluation of Thrombotic Microangiopathy](https://i.ytimg.com/vi/Zf4TA8gVTG4/default.jpg)
![Splenectomy Versus Other Therapy in ITP](https://i.ytimg.com/vi/KbvDhM5UJ9o/default.jpg)
![Immune Thrombocytopenia (ITP) | Most COMPREHENSIVE Explanation](https://i.ytimg.com/vi/7IUt0AAvy3E/default.jpg)
![I Have An AutoImmune Disease](https://i.ytimg.com/vi/kron722MlZA/default.jpg)
![فرفرية نقص الصفائح الدموية مجهولة السبب ITP](https://i.ytimg.com/vi/LcOQZbebgQ0/default.jpg)
![Thrombotic Thrombocytopenic Purpura (TTP)](https://i.ytimg.com/vi/42jKU6IJblA/default.jpg)
![What Causes High Platelets (Thrombocytosis) | Approach to Causes, Symptoms, Treatment](https://i.ytimg.com/vi/e7r5zMoI7jc/default.jpg)
![Idiopathic Thrombocytopenic Purpura (ITP) Disease | Dr Ammar Aslam](https://i.ytimg.com/vi/fw2qhi6EInM/default.jpg)
![Understanding Immune Thrombocytopenia: Perspectives in ITP](https://i.ytimg.com/vi/8IC8DOSdWRk/default.jpg)
![ISTH Academy Presentation: Acquired Thrombotic Thrombocytopenic Purpura](https://i.ytimg.com/vi/1jNqgkePuAU/default.jpg)